362 related articles for article (PubMed ID: 29727583)
1. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of siPTPN13 and siNOX4
Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X
Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085
[No Abstract] [Full Text] [Related]
3. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
[TBL] [Abstract][Full Text] [Related]
5. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
6. FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.
Nho RS; Peterson M; Hergert P; Henke CA
PLoS One; 2013; 8(4):e61017. PubMed ID: 23580232
[TBL] [Abstract][Full Text] [Related]
7. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
Tzouvelekis A; Yu G; Lino Cardenas CL; Herazo-Maya JD; Wang R; Woolard T; Zhang Y; Sakamoto K; Lee H; Yi JS; DeIuliis G; Xylourgidis N; Ahangari F; Lee PJ; Aidinis V; Herzog EL; Homer R; Bennett AM; Kaminski N
Am J Respir Crit Care Med; 2017 Feb; 195(4):500-514. PubMed ID: 27736153
[TBL] [Abstract][Full Text] [Related]
8. MUC1 intracellular bioactivation mediates lung fibrosis.
Milara J; Ballester B; Montero P; Escriva J; Artigues E; Alós M; Pastor-Clerigues A; Morcillo E; Cortijo J
Thorax; 2020 Feb; 75(2):132-142. PubMed ID: 31801904
[TBL] [Abstract][Full Text] [Related]
9. Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis.
Wynes MW; Edelman BL; Kostyk AG; Edwards MG; Coldren C; Groshong SD; Cosgrove GP; Redente EF; Bamberg A; Brown KK; Reisdorph N; Keith RC; Frankel SK; Riches DW
J Immunol; 2011 Jul; 187(1):527-37. PubMed ID: 21632719
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
[TBL] [Abstract][Full Text] [Related]
12. X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.
Ajayi IO; Sisson TH; Higgins PD; Booth AJ; Sagana RL; Huang SK; White ES; King JE; Moore BB; Horowitz JC
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):86-95. PubMed ID: 23492187
[TBL] [Abstract][Full Text] [Related]
13. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
Al-Tamari HM; Dabral S; Schmall A; Sarvari P; Ruppert C; Paik J; DePinho RA; Grimminger F; Eickelberg O; Guenther A; Seeger W; Savai R; Pullamsetti SS
EMBO Mol Med; 2018 Feb; 10(2):276-293. PubMed ID: 29217661
[TBL] [Abstract][Full Text] [Related]
14. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
[TBL] [Abstract][Full Text] [Related]
15. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.
Cha SI; Groshong SD; Frankel SK; Edelman BL; Cosgrove GP; Terry-Powers JL; Remigio LK; Curran-Everett D; Brown KK; Cool CD; Riches DW
Am J Respir Cell Mol Biol; 2010 Feb; 42(2):140-8. PubMed ID: 19372246
[TBL] [Abstract][Full Text] [Related]
16. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
17. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.
Huang SK; Scruggs AM; Donaghy J; Horowitz JC; Zaslona Z; Przybranowski S; White ES; Peters-Golden M
Cell Death Dis; 2013 May; 4(5):e621. PubMed ID: 23640463
[TBL] [Abstract][Full Text] [Related]
18. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
19. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
[TBL] [Abstract][Full Text] [Related]
20. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]